BeiGene Corp (ONC) - Earnings growth forecast for next year
BeiGene Ltd (ONC) is implementing AI to accelerate molecule discovery while maintaining strict medical oversight. The company is reducing its dependence on China through the global promotion of its flagship drug. Its strategy for capturing Western markets relies on an accessible clinical base. GURU.Markets quotes drive this chart of analyst EPS growth estimates, where the current value is 19.20.
Metric breakdowns and analytics for BeiGene Ltd. (ONC)
- share price and consensus valuation forecast:
- market capitalization indicators:
- book capitalization indicators:
- issuer credit burden and liquidity indicators:
- earnings and valuation multiples information:
ONC - Company Net Income|Future Profit BeiGene Ltd|ONC - Market Price to Net Income Ratio|Forward P/E Multiple BeiGene Corp|ONC - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BeiGene|ONC - Profit before interest, taxes and amortization|Earnings per share for the last twelve months BeiGene|ONC - Earnings per share for the last 12 months|Quarterly EPS earnings growth beigene.com|ONC - Net earnings per share growth this year|Earnings growth forecast for next year BeiGene Ltd
- revenue and sales details:
General company analysis:BeiGene Ltd., ONC
High capacity utilization and the modernization of BeiGene Ltd (ONC) oncology manufacturing plants determine the future profitability of the business. This indicator measures the expected percentage growth in earnings per share by aggregating forecasts from leading US analysts. Investors use this metric to filter for assets with sustainable capitalization potential. A systematic decline in the consensus net income growth estimate signals risks of investment impairment.
Competitors of BeiGene Ltd
HALO (Halozyme Therapeutics, Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year revmed.com RVMD|Earnings growth forecast for next year AAPG|Expected earnings per share growth for next year CG Oncology CGON|Net earnings per share growth forecast for next year UroGen URGN|Consensus forecast of earnings per share growth for next year Bicara Bio (BCAX)|PSNL - Net earnings per share growth forecast for next year|ERAS - Earnings growth forecast for next year|DCTH: Earnings growth forecast for next year|Y-mAbs Therapeutics, Inc. (YMAB) - Earnings growth forecast for next year|Expected earnings per share growth for next year AURA|Expected net earnings per share growth next year candeltx.com CADL|Earnings growth forecast for next year ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year ACTU (Actuate Therapeutics Inc)|Expected earnings per share trend next year CTOR|tuhurabio.com - Earnings growth forecast for next year|Expected earnings per share trend next year TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Net earnings per share growth forecast for next year|WHWK - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year tscan.com|CSBR: Expected earnings per share trend next year|Net earnings per share growth forecast for next year XBiotech USA (XBIT)|CVM: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year ostherapies.com OSTX|Projected earnings per share increase next year RADX (Radiopharm Theranostics Limited)|Artiva - Earnings growth forecast for next year|ANL: Net earnings per share growth forecast for next year|VERU: Earnings growth forecast for next year|Net earnings per share change forecast for next year TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Earnings growth forecast for next year|Expected net earnings per share growth next year renovarobio.com RENB|Net earnings per share growth forecast for next year muraloncology.com (MURA)|Projected earnings per share increase next year KAPA|Earnings growth forecast for next year OKUR (onkuretherapeutics.com)|Projected earnings per share increase next year GDTC (CytoMed)|Curis - Earnings growth forecast for next year|APLM: Net earnings per share growth forecast for next year|Tharimmune (THAR) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Advanced Biomed Inc.|GNPX (Genprex Inc) - Earnings growth forecast for next year|Calidi Biotherapeutics (CLDI) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year SBFM|Net earnings per share growth forecast for next year XBIO (Xenetic Biosciences, Inc.)|Earnings growth forecast for next year SLRX (salariuspharma.com)|PPBT - Expected earnings per share growth for next year|AONC - Net earnings per share growth forecast for next year|Expected earnings per share trend next year BGNE (BeOne Medicines)|CKPT: Earnings growth forecast for next year|Elevation Oncology Inc. (ELEV) - Earnings growth forecast for next year|ICAD (iCAD) - Earnings growth forecast for next year|Earnings growth forecast for next year ikenaoncology.com|Earnings growth forecast for next year NTBL|Earnings growth forecast for next year Viracta Therapeutics Inc. (VIRX)|Net earnings per share growth forecast for next year MorphoSys Inc MOR|Expected earnings per share trend next year NAYA|AAPGV: Expected earnings per share growth for next year
